GlassScriptPhysician profile
Rahul A Patel
NPI 1790893535
$5,557.89
in general payments reported to CMS, 2019-2025
23 companies · $428 in 2025
The $428 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,326 · 2020: $908 · 2021: $1,009 · 2022: $699 · 2023: $405 · 2024: $784 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,615.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,121.39 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,050.69 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Medtronic Vascular, INC. | $636.26 | 2019-2020 | |
| Lilly USA, LLC | $509.58 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Medtronic, INC. | $442.79 | 2021-2022 | |
| Abbvie INC. | $343.54 | 2019-2025 | |
| Abbott Laboratories | $279.50 | 2023-2024 | Freestyle Libre 3 |
| Pfizer INC. | $196.39 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $144.41 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $136.38 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $101.85 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $100.79 | 2019-2022 | |
| Amgen INC. | $92.13 | 2023-2025 | Repatha, Tepezza, Otezla |
| Sanofi-Aventis U.S. LLC | $86.86 | 2019 | |
| Corcept Therapeutics | $74.23 | 2024-2025 | Korlym |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $65.18 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $40.99 | 2020 | |
| Janssen Pharmaceuticals, INC | $35.63 | 2020-2023 | Xarelto |
| Allergan, INC. | $34.15 | 2020 | |
| Exact Sciences Corporation | $20.18 | 2024 | Cologuard Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $17.39 | 2022 | |
| Eisai INC. | $15.29 | 2021 | |
| Horizon Therapeutics Plc | $12.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rahul Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.